Chemoinformaics analysis of di-glycosides of kaempferol
| Molecular Weight | 286.239 | nRot | 1 |
| Heavy Atom Molecular Weight | 276.159 | nRig | 18 |
| Exact Molecular Weight | 286.048 | nRing | 3 |
| Solubility: LogS | -3.624 | nHRing | 1 |
| Solubility: LogP | 2.656 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 31 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 21 | No. of Aromatic Carbocycles | 2 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 17 |
| nHA | 6 | APOL | 36.5299 |
| nHD | 4 | BPOL | 12.6361 |
| QED | 0.546 |
| Synth | 2.375 |
| Natural Product Likeliness | 1.546 |
| NR-PPAR-gamma | 0.963 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.004 |
| Pgp-sub | 0.011 |
| HIA | 0.008 |
| CACO-2 | -4.974 |
| MDCK | 0.00000907 |
| BBB | 0.009 |
| PPB | 0.978613 |
| VDSS | 0.522 |
| FU | 0.0441197 |
| CYP1A2-inh | 0.972 |
| CYP1A2-sub | 0.11 |
| CYP2c19-inh | 0.181 |
| CYP2c19-sub | 0.046 |
| CYP2c9-inh | 0.653 |
| CYP2c9-sub | 0.867 |
| CYP2d6-inh | 0.722 |
| CYP2d6-sub | 0.283 |
| CYP3a4-inh | 0.697 |
| CYP3a4-sub | 0.08 |
| CL | 6.868 |
| T12 | 0.905 |
| hERG | 0.07 |
| Ames | 0.672 |
| ROA | 0.156 |
| SkinSen | 0.856 |
| Carcinogencity | 0.097 |
| EI | 0.929 |
| Respiratory | 0.09 |
| NR-Aromatase | 0.941 |
| Antiviral | Yes |
| Prediction | 0.724554 |